Global Vacuum-Assisted Breast Biopsy Device Market By Procedure: Tethered, Untethered

Breast cancer is one of the most common diseases afflicting women worldwide, both in developed and developing nations. According to the American Cancer Society, breast cancer is the second leading cause of cancer-related deaths in women worldwide. The rising number of breast cancer cases has compelled governments worldwide to raise awareness about the importance of early detection, which is expected to drive growth in the vacuum-assisted breast biopsy device market.

The vacuum-assisted breast biopsy (VABB) has a faster response time than other diagnostic devices. The rising prevalence of breast cancer is propelling the vacuum-assisted breast biopsy market forward. Vacuum-assisted breast biopsy (VABB) devices are gaining popularity over traditional biopsy methods due to their ability to obtain large amounts of tissues with contiguous specimens, the ability to obtain multiple specimens with a single needle insertion, a more accurate diagnosis with a lower cancer miss rate, and lower histological underestimates.

Download Sample Report : https://skyquestt.com/sample-request/vacuum-assisted-breast-biopsy-device-market

The vacuum-assisted breast biopsy device market is expanding as a result of a robust research environment that has contributed to the development of more accurate and minimally invasive treatments for breast cancer detection. Governments have also made efforts to foster a stable and all-encompassing environment for cancer research, which has aided in the development of these diagnostic devices. Furthermore, attractive reimbursements have significantly improved the sector's health. Breast cancer awareness campaigns are increasing public awareness about the importance of early detection of breast cancer, which is driving market growth.

Read market research report, " Global Vacuum-Assisted Breast Biopsy Device Market By Procedure (Tethered, Untethered), By Product (Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles), By Type ( 9-12G, 12G), By Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), By End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others) & By Region - Forecast and Analysis 2022-2028" by SkyQuest

Get full report : https://skyquestt.com/report/vacuum-assisted-breast-biopsy-device-market

The vacuum-assisted breast biopsy device market is currently dominated by North America, and this trend is anticipated to continue throughout the projected period. During the forecast period, the vacuum-assisted breast biopsy device market in North America is anticipated to expand at a CAGR of 4.4%. In the United States, more than 1 million breast biopsies are carried out annually. In order to help people identify any abnormalities in their breasts that would be further diagnosed by a doctor, the American Cancer Society advises women to take part in self-awareness tests offered throughout the year. Furthermore, the Asia-Pacific region has the fastest-growing market . Over the past few decades, the number of breast cancer cases in Asian nations has increased dramatically. A study on breast cancer in Asia found that higher prevalences of breast cancer risk factors, such as postponed childbirth and increasing obesity, led to an increase in breast cancer mortality among Asian women.

The Global vacuum-assisted breast biopsy device market is dominated by Becton Dickinson and Co (Bd), Devicor Medical Products Inc (Mammotome) and Hologic Inc. To gain a significant market share, key players in the vacuum-assisted breast biopsy device market are employing strategies such as product launch, merger and acquisition, and high R&D investments. For instance, IZI Medical Products, LLC introduced The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy in March 2021. Quick-Core Auto is a portable, fully automatic biopsy system that provides the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system.

The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.

Drivers
• Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods. VABB is a recognized method of therapeutic removal of benign lesions such as fibroadenomas. It can reduce the need for open surgical biopsy or excision, and minimize costs. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.
Restraint
• VABB has a higher capital cost, such as vacuum generators and biopsy hand-pieces, as well as a higher running cost of consumables such as needles, tubing, and localising markers. VABB is frequently used as a second line of biopsy in some hospitals and research centres due to its higher cost when compared to fine needle aspiration (FNA) biopsy or core biopsy. In such cases, VABB is only performed after insufficient or inconclusive cytology or histology, or when previous FNA or core biopsies produced contradictory imaging-pathology results.

Buy this full report : https://skyquestt.com/buy-now/vacuum-assisted-breast-biopsy-device-market

What does this Report Deliver?
• Market Estimation for 20+ Countries
• Customization on Segments, Regions, and Company Profiles
• 100+ tables, 150+ Figures
• Global and Country Vacuum-Assisted Breast Biopsy Device Market Trends
• Comprehensive Mapping of Vacuum-Assisted Breast Biopsy Device Industry Parameters
• Attractive Investment Proposition
• Competitive Strategies Adopted by Leading Vacuum-Assisted Breast Biopsy Device Market Players
• Vacuum-Assisted Breast Biopsy Device Market drivers, restraints, opportunities, and impact on the market
• Vacuum-Assisted Breast Biopsy Device Market growth rate till 2028
• Regulatory scenario, regional dynamics, and Vacuum-Assisted Breast Biopsy Device Market insights of leading countries in each region
• Segment trends and analysis
• Vacuum-Assisted Breast Biopsy Device Market Opportunity analysis by region and country
• Vacuum-Assisted Breast Biopsy Device Market Segmentation opportunity and growth
• Porter's five force analysis to know the market's condition
• Pricing analysis
• Parent market analysis
• Product portfolio benchmarking

SkyQuest has segmented the Global Vacuum-Assisted Breast Biopsy Device Market based on the Procedure, Product, Type, Technique, End user, and Region:
• Global Vacuum-Assisted Breast Biopsy Device Market by Procedure (Revenue, USD Million, 2022 - 2028)
o Tethered
o Untethered
• Global Vacuum-Assisted Breast Biopsy Device Market by Product (Revenue, USD Million, 2022 - 2028)
o Vacuum-Assisted Biopsy Systems
o Vacuum-Assisted Biopsy Needles
• Global Vacuum-Assisted Breast Biopsy Device Market by Type (Revenue, USD Million, 2022 - 2028)
o 9-12G
o 12G
• Global Vacuum-Assisted Breast Biopsy Device Market by Technique (Revenue, USD Million, 2022 - 2028)
o Ultrasound-Guided Biopsy
o Stereotactic-Guided Biopsy
o MRI-Guided Biopsy
o Others
• Global Vacuum-Assisted Breast Biopsy Device Market by End-User (Revenue, USD Million, 2022 - 2028)
o Hospitals
o Academic and Research Institutes
o Diagnostic and Imaging Centers
o Others
• Global Vacuum-Assisted Breast Biopsy Device Market Regional Outlook (Revenue, USD Million, 2022 - 2028)
o North America
 US
 Canada
o Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Rest of Asia Pacific
o Central & South America
 Brazil
 Rest of CSA
o Middle East & Africa
 GCC Countries
 South Africa
 Rest of MEA

Speak with our analyst for more information: https://skyquestt.com/speak-with-analyst/vacuum-assisted-breast-biopsy-device-market

Key Players of Global Vacuum-Assisted Breast Biopsy Device Market
• BD (US)
• Cook (US)
• Devicor Medical Products, Inc. (US)
• ARGON MEDICAL. (US)
• Cardinal Health. (US)
• Olympus Corporation (Japan)
• Boston Scientific Corporation (US)
• INRAD Inc. (US)
• Medtronic (Ireland)
• Hologic, Inc. (US)

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

Website: https://skyquestt.com/

This release was published on openPR.